gov.uk· MHRA (UK)·· 17 hours agoScore68
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
In brief
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved deuruxolitinib (brand name Leqselvi) to treat severe alopecia areata in adults, and says it will keep the safety and effectiveness of the medicine under close review.
Source: gov.uk · gov.uk